ATE293986T1 - Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester - Google Patents

Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester

Info

Publication number
ATE293986T1
ATE293986T1 AT96921738T AT96921738T ATE293986T1 AT E293986 T1 ATE293986 T1 AT E293986T1 AT 96921738 T AT96921738 T AT 96921738T AT 96921738 T AT96921738 T AT 96921738T AT E293986 T1 ATE293986 T1 AT E293986T1
Authority
AT
Austria
Prior art keywords
aspartyl
phenylalanine
alpha
methyl ester
pain relieving
Prior art date
Application number
AT96921738T
Other languages
English (en)
Inventor
Allen B Edmundson
Carl V Manion
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of ATE293986T1 publication Critical patent/ATE293986T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Seasonings (AREA)
AT96921738T 1995-06-23 1996-06-21 Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester ATE293986T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47995P 1995-06-23 1995-06-23
US08/590,409 US5654334A (en) 1995-06-23 1996-01-25 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
PCT/US1996/010716 WO1997000692A1 (en) 1995-06-23 1996-06-21 ANALGESIC USE OF N-L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER

Publications (1)

Publication Number Publication Date
ATE293986T1 true ATE293986T1 (de) 2005-05-15

Family

ID=26667704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921738T ATE293986T1 (de) 1995-06-23 1996-06-21 Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester

Country Status (8)

Country Link
US (2) US5654334A (de)
EP (1) EP0833651B1 (de)
JP (1) JP2000502318A (de)
AT (1) ATE293986T1 (de)
AU (1) AU722460B2 (de)
CA (1) CA2225462A1 (de)
DE (1) DE69634662T2 (de)
WO (1) WO1997000692A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
JP2001505188A (ja) 1996-09-26 2001-04-17 オゥクラホゥマ、メディカル、リサーチ、ファウンデイシャン Ｎ―Ｌ―α―アスパルチル―Ｌ―フェニルアラニン１―メチルエステル及びその誘導体の疾患後退への使用
US6156795A (en) * 1997-12-22 2000-12-05 Oklahoma Medical Research Foundation N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its derivatives for appetite enhancement
US6326400B1 (en) 1999-08-27 2001-12-04 Allen B. Edmundson N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its derivatives for appetite enhancement
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
US6919374B1 (en) 1999-09-25 2005-07-19 Oklahoma Medical Research Foundation Viscosity modulating substance and use thereof
WO2001022983A2 (en) * 1999-09-25 2001-04-05 Oklahoma Medical Research Foundation Viscosity modulating substance and use thereof
JP2005060311A (ja) * 2003-08-13 2005-03-10 Mochida Pharmaceut Co Ltd Ｎ−（ベンゾイル）アミノ酸誘導体を有効成分とするニューロパシー性疼痛治療剤
US7288527B2 (en) * 2004-04-27 2007-10-30 Oklahoma Medical Research Foundation Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
US20050277597A1 (en) * 2004-06-10 2005-12-15 Oklahoma Medical Research Foundation Use of N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester to treat sunburn and other burns
EP1998781A2 (de) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware Schmerzbehandlung
MX2016008459A (es) 2013-12-24 2016-10-14 Univ Virginia Commonwealth Usos de sulfatos de colesterol oxigenados (soc).

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3492131A (en) * 1966-04-18 1970-01-27 Searle & Co Peptide sweetening agents
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
EP0358758A1 (de) * 1987-04-09 1990-03-21 Terumo Kabushiki Kaisha Mittel zur abtrennung von b-lymphozyten und mittel zur klärung von körperflüssigkeiten
JPH0832627B2 (ja) * 1988-02-16 1996-03-29 三井東圧化学株式会社 二日酔予防治療剤
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
FR2649611A1 (fr) * 1989-07-13 1991-01-18 Philippe Perovitch Procede de preparation galenique d'une composition therapeutique notamment a base d'aspirine
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
BE1007099A5 (fr) * 1993-11-22 1995-03-14 Messadek Jallal Activite medicamenteuse de l'aspartame.
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester

Also Published As

Publication number Publication date
DE69634662T2 (de) 2006-03-02
AU722460B2 (en) 2000-08-03
CA2225462A1 (en) 1997-01-09
DE69634662D1 (de) 2005-06-02
AU6287896A (en) 1997-01-22
EP0833651A1 (de) 1998-04-08
JP2000502318A (ja) 2000-02-29
EP0833651B1 (de) 2005-04-27
WO1997000692A1 (en) 1997-01-09
US5654334A (en) 1997-08-05
US5998473A (en) 1999-12-07

Similar Documents

Publication Publication Date Title
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
DE69226369D1 (de) System mit erhöhender Hautpenetration für verbesserte topische Verabreichung von Arzneimitteln
ATE293986T1 (de) Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
GB2340039B (en) Improved delivery of drugs to mucosal surfaces
MX9600065A (es) Polisacaridos acidicos reticulados y sus usos.
DE69735848D1 (de) Dosisform mit ansteigender dosisfreisetzung
CA2274074A1 (en) Novel compounds with analgesic effect
BR9711671A (pt) Tratamento com ácido graxo.
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
CA2239174A1 (en) Novel compounds with analgesic effect
SI1572167T1 (sl) Transdermalni buprenorfinski dozirni reĹľim za analgezijo
HK1028957A1 (en) Use of n,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of chronic pain
DE59308292D1 (de) Substituierte triole
DE69230314D1 (de) Cytokinhemmer
TR199701520T1 (xx) Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu.
BR9508671A (pt) Método de alívio da dor e composição terapêutica
EP0906757A3 (de) Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält
FI945446A0 (fi) Kotiinin käyttö tupakan vieroitusoireyhtymän lievittämiseksi
AUPP379698A0 (en) Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
EP1374873B8 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
Drusan et al. The granulocytopenic cancer patient. When and how to initiate empiric antimicrobial therapy.
AU1305999A (en) (+)-ephedrine as a sympathomimetic drug
IT1271350B (it) Derivati di 3,8 diazabiciclo (3,2,1) - ottani quali medicamenti ad attivita' analgesica centrale
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties